- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Hemogenomics covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (80), financial health (95), director (90) and company-foundation signals.
- Operating for 24+ years.
- Company status is Active as per MCA.
- Annual filings up to date (balance sheet as of Mar 2025).
- Profitable in FY 2025.
- Positive net worth.
- 3 directors on the board.
- No disqualified or deactivated DINs on the current board.
About Hemogenomics
Hemogenomics is an MCA-registered Indian company: a Private Limited Indian Non-Government Company (CIN U73100KA2002PTC030032). Business overview includes Healthcare (Diagnostic Centers & Pathology Labs), incorporated on January 22, 2002 (24+ years old), headquartered in Bangalore., Karnataka, India. The company is currently Active with Active Compliant compliance status.
- Location Kemwell House,No.11, Tumkur Road Bangalore., Bangalore., Karnataka - 560022
- Website hemogenomics.com
Financial Performance of Hemogenomics
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Hemogenomics (3)
Charges of Hemogenomics
| Lender | Amount | Status |
|---|---|---|
|
The Hongkong And Shanghai Banking Corporation Limited
Creation Date: 28 Jun 2025 |
27.50 cr | Open |
|
Others
Creation Date: 20 Feb 2025 |
1.04 cr | Open |
|
Citi Bank N.A.
Creation Date: 02 Mar 2016 |
5.00 cr | Open |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Hospital and Medical Care | - | 20.40 |
| Trade | - | 79.28 |
Flagged By Authority
Regulatory and exchange flags (preview)
Legal Cases of Hemogenomics
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
